These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38517161)

  • 21. Additional features of unique Primrose syndrome phenotype.
    Carvalho DR; Speck-Martins CE
    Am J Med Genet A; 2011 Jun; 155A(6):1379-83. PubMed ID: 21567911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial.
    Lewis G; Duffy L; Ades A; Amos R; Araya R; Brabyn S; Button KS; Churchill R; Derrick C; Dowrick C; Gilbody S; Fawsitt C; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Khan N; Lanham P; Pervin J; Peters TJ; Riozzie D; Salaminios G; Thomas L; Welton NJ; Wiles N; Woodhouse R; Lewis G
    Lancet Psychiatry; 2019 Nov; 6(11):903-914. PubMed ID: 31543474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay.
    Machol K; Rousseau J; Ehresmann S; Garcia T; Nguyen TTM; Spillmann RC; Sullivan JA; Shashi V; Jiang YH; Stong N; Fiala E; Willing M; Pfundt R; Kleefstra T; Cho MT; McLaughlin H; Rosello Piera M; Orellana C; Martínez F; Caro-Llopis A; Monfort S; Roscioli T; Nixon CY; Buckley MF; Turner A; Jones WD; van Hasselt PM; Hofstede FC; van Gassen KLI; Brooks AS; van Slegtenhorst MA; Lachlan K; Sebastian J; Madan-Khetarpal S; Sonal D; Sakkubai N; Thevenon J; Faivre L; Maurel A; Petrovski S; Krantz ID; Tarpinian JM; Rosenfeld JA; Lee BH; ; Campeau PM
    Am J Hum Genet; 2019 Jan; 104(1):164-178. PubMed ID: 30580808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HTTLPR polymorphism of serotonin transporter and effects of sertraline in terminally ill cancer patients: report of eleven cases.
    Schillani G; Capozzo MA; Aguglia E; De Vanna M; Grassi L; Conte MA; Giraldi T
    Tumori; 2008; 94(4):563-7. PubMed ID: 18822694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
    Sechter D; Troy S; Paternetti S; Boyer P
    Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.
    Ball SG; Kuhn A; Wall D; Shekhar A; Goddard AW
    J Clin Psychiatry; 2005 Jan; 66(1):94-9. PubMed ID: 15669894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evidence-based review of the clinical use of sertraline in mood and anxiety disorders.
    Sheehan DV; Kamijima K
    Int Clin Psychopharmacol; 2009 Mar; 24(2):43-60. PubMed ID: 21456103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of early administration of sertraline on cognitive and behavioral recovery in the first year after moderate to severe traumatic brain injury.
    Baños JH; Novack TA; Brunner R; Renfroe S; Lin HY; Meythaler J
    J Head Trauma Rehabil; 2010; 25(5):357-61. PubMed ID: 20220529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sertraline in stroke-associated lability of mood.
    Burns A; Russell E; Stratton-Powell H; Tyrell P; O'Neill P; Baldwin R
    Int J Geriatr Psychiatry; 1999 Aug; 14(8):681-5. PubMed ID: 10489659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin syndrome from sertraline monotherapy.
    Duignan KM; Quinn AM; Matson AM
    Am J Emerg Med; 2020 Aug; 38(8):1695.e5-1695.e6. PubMed ID: 31837902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of aggression and irritability after head injury.
    Kant R; Smith-Seemiller L; Zeiler D
    Brain Inj; 1998 Aug; 12(8):661-6. PubMed ID: 9724837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin syndrome in maintenance haemodialysis patients following sertraline treatment for depression.
    Chander WP; Singh N; Mukhiya GK
    J Indian Med Assoc; 2011 Jan; 109(1):36-7. PubMed ID: 21888157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.
    Russell JM; Koran LM; Rush J; Hirschfeld RM; Harrison W; Friedman ES; Davis S; Keller M
    Depress Anxiety; 2001; 13(1):18-27. PubMed ID: 11233456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
    Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
    Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.
    Walkup JT; Albano AM; Piacentini J; Birmaher B; Compton SN; Sherrill JT; Ginsburg GS; Rynn MA; McCracken J; Waslick B; Iyengar S; March JS; Kendall PC
    N Engl J Med; 2008 Dec; 359(26):2753-66. PubMed ID: 18974308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open trial of sertraline in personality disordered patients with impulsive aggression.
    Kavoussi RJ; Liu J; Coccaro EF
    J Clin Psychiatry; 1994 Apr; 55(4):137-41. PubMed ID: 8071257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
    Pediatric OCD Treatment Study (POTS) Team
    JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sertraline hepatotoxicity: report of a case and review of the literature.
    Tabak F; Gunduz F; Tahan V; Tabak O; Ozaras R
    Dig Dis Sci; 2009 Jul; 54(7):1589-91. PubMed ID: 18958618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.
    MacQueen G; Born L; Steiner M
    CNS Drug Rev; 2001; 7(1):1-24. PubMed ID: 11420570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregabalin versus sertraline in generalized anxiety disorder. An open label study.
    Cvjetkovic-Bosnjak M; Soldatovic-Stajic B; Babovic SS; Boskovic K; Jovicevic M
    Eur Rev Med Pharmacol Sci; 2015; 19(11):2120-4. PubMed ID: 26125277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.